DEDICATED TO SAVING LIVES

About Asamedic

Asamedic is a Norwegian pharmaceutical company established in 2013 with the purpose of developing a drug against acute myocardial infarction

Read more

Asamedic on LinkedIn

You can read about the development of Asamedic on our LinkedIn Page.

Click here: LinkedIn Page .

The leading cause of death globally is ischaemic heart disease, a condition that can ultimately lead to heart attacks*

Asamedic was founded on a personal motivation to find a way to reduce mortality from heart attacks. Through research and innovation, we aim to contribute to save lives.

*Source: WHO Global Health Estimates.